Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Freed, Benjamin H ^a   Gomberg Maitland, Mardi ^a   Chandra, Sonal ^a   Mor Avi, Victor ^a   Rich, Stuart ^a   Archer, Stephen L ^a   Jamison, E Bruce ^a   Lang, Roberto M ^a   Patel, Amit R ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; GADOLINIUM; PROSTACYCLIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; DEATH; DISEASE SEVERITY; EXERCISE; EXERCISE TEST; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HUMAN; LUNG ARTERY PRESSURE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; UNIVARIATE ANALYSIS; BLOOD; BLOOD PRESSURE; CHI SQUARE DISTRIBUTION; DISEASE COURSE; HEART FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PULMONARY ARTERY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; UNITED STATES;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; CHICAGO; CONTRAST MEDIA; DISEASE PROGRESSION; EXERCISE TEST; FEMALE; GADOLINIUM DTPA; HEART CATHETERIZATION; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY ARTERY; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; TIME FACTORS; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT;

EID: 84860581011     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-11     Document Type: Article

References (26)

1. Treatment of pulmonary arterial hypertension. Humbert M, Sitbon O, Simonneau G, N Engl J Med 2004 351 1425 1436 10.1056/NEJMra040291 15459304 (Pubitemid 39302645)
2. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, Levy PS, Pietra GG, Reid LM, Reeves JT, Rich S, Vreim CE, Williams GW, Wu M, Ann Intern Med 1991 115 343 9 1863023
3. Predicting survival in pulmonary arterial hypertension: Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Benza RL, Miller DP, Gomberg-Maitland M, Circulation 2010 122 164 172 10.1161/CIRCULATIONAHA.109.898122 20585012
4. Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension. Benza RL, Biederman R, Murali S, Gupta H, J Am Coll Cardiol 2008 52 1683 92 10.1016/j.jacc.2008.08.033 19007687
5. Comprehensive invasive and noninvasive approach to the right ventricle pulmonary circulation unit: State of the art and clinical and research implications. Champion HC, Michelakis ED, Hassoun PM, Circulation 2009 120 992 1007 10.1161/CIRCULATIONAHA.106.674028 19752350
6. Measuring the heart in pulmonary arterial hypertension (PAH): Implications for trial study size. Bradlow WM, Hughes ML, Keenan NG, Bucciarelli-Ducci C, Assomull R, Gibbs JS, Mohiaddin RH, J Magn Reson Imaging 2010 31 117 124 10.1002/jmri.22011 20027579
7. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Blyth KG, Groenning BA, Martin TN, Foster JE, Mark PB, Dargie HJ, Peacock AJ, Eur Heart J 2005 26 1993 1999 10.1093/eurheartj/ ehi328 15899927 (Pubitemid 41435724)
8. Extent of MRI delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension. McCann GP, Gan CT, Beek AM, Niessen HWM, Noordegraaf AV, van Rossum AC, Am J Roentgenol 2007 188 349 355 10.2214/AJR.05.1259 (Pubitemid 46167734)
9. Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. Sanz J, Dellegrottaglie S, Kariisa M, Sulica R, Poon M, O'Donnell TP, Mehta D, Fuster V, Rajagopalan S, Am J Cardiol 2007 100 731 735 10.1016/j.amjcard.2007.03.094 17697838 (Pubitemid 47223155)
10. Myocardial delayed enhancement in patients with pulmonary hypertension and right ventricular failure: Evaluation by cardiac MRI. Junqueira FP, Macedo R, Coutinho AC, Loureiro R, De Pontes PV, Domingues RC, Gasparetto EL, Br J Radiol 2009 82 821 826 10.1259/bjr/28241773 19398466
11. Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling. Shehata ML, Lossnitzer D, Skrok J, Boyce D, Lechtzin N, Mathai SC, Girgis RE, Osman N, Lima JA, Bluemke DA, Hassoun PM, Vogel-Claussen J, AJR Am J Roentgenol 2011 196 87 94 10.2214/AJR.09.4114 21178051
12. Medical therapy for pulmonary arterial hypertension: Updated ACCP evidence-based clinical practice guidelines. Badesch DB, Adman SH, Simonneau G, Rubin LJ, McLaughlin VV, Chest 2007 131 1917 1928 10.1378/chest.06-2674 17565025 (Pubitemid 46981654)
13. Clinical classification of pulmonary hypertension. Sinmonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A, J Am Coll Cardiol 2004 43 5S 12S 10.1016/j.jacc.2004.02.037 15194173 (Pubitemid 38759712)
14. Normal human left and right ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP Jr, J Cardiovasc Magn Reson 1999 1 7 21 10.3109/10976649909080829 11550343
15. Treadmill exercise in assessment of the functional capacity of patients with cardiac disease. Patterson JA, Naughton J, Pietras RJ, Gunnar RM, Am J Cardiol 1972 30 757 762 10.1016/0002-9149(72)90151-8 5084774
16. Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension. Gomberg-Maitland M, Huo D, Benza RL, McLaughlin VV, Tapson VF, Barst RJ, J Heart Lung Transplant 2007 26 732 738 10.1016/j.healun.2007.04.013 17613405 (Pubitemid 47001713)
17. The prognostic value of a nomogram for exercise capacity in women. Gulati M, Black HR, Shaw LJ, Arnsdorf MF, Merz CN, Lauer MS, Marwick TH, Pandey DK, Wicklund RH, Thisted RA, N Engl J Med 2005 353 468 475 10.1056/NEJMoa044154 16079370 (Pubitemid 41127291)
18. Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men. Morris CK, Myers J, Froelicher VF, Kawaguchi T, Ueshima K, Hideg A, J Am Coll Cardiol 1993 22 175 182 10.1016/0735-1097(93) 90832-L 8509539 (Pubitemid 23189950)
19. MIX 2.0. Professional software for meta-analysis in Excel. Version (2.0.1.1). BiostatXL, 2010. Bax L, https://www.meta-analysis-made-easy.com
20. Value of exercise stress testing in the risk stratification of patients with pulmonary hypertension. Shah SJ, Thenappan T, Rich S, Sur J, Archer SL, Gomberg-Maitland M, Circ Heart Fail 2009 2 278 286 10.1161/CIRCHEARTFAILURE.108. 807826 19808350
21. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. van Wolferen SA, Marcus JT, Boonstra A, Marques KM, Bronzwaer JG, Spreeuwenberg MD, Postmus PE, Vonk-Noordegraaf A, Eur Heart J 2007 28 1250 1257 10.1093/eurheartj/ehl477 17242010 (Pubitemid 47343830)
22. Use of noninvasive tools in primary pulmonary hypertension to assess the correlation of right ventricular function with functional capacity and to predict outcome. Zafrir N, Zingerman B, Solodky A, Ben-Dayan D, Sagie A, Sulkes J, Mats I, Kramer MR, Int J Cardiovasc Imaging 2007 23 209 215 10.1007/s10554-006-9140-5 16972146 (Pubitemid 46431545)
23. New predictors of outcome in idiopathic pulmonary arterial hypertension. Kawut S, Horn EM, Berekashvili KK, Garofano RP, Goldsmith RL, Widlitz AC, Rosenzweig EB, Kerstein D, Barst RJ, Am J Cardiol 2005 95 199 203 10.1016/j.amjcard.2004.09.006 15642552 (Pubitemid 40092084)
24. Right ventricular ischemia in patients with primary pulmonary hypertension. Gomez A, Bialostozky D, Zajarias A, Santos E, Palomar A, Martinez ML, Sandoval J, J Am Coll Cardiol 2001 38 1137 1142 10.1016/S0735-1097(01)01496- 6 11583894 (Pubitemid 32912723)
25. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Moon JCC, Reed E, Sheppard M, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ, J Am Coll Cardiol 2004 43 2260 4 10.1016/j.jacc.2004.03.035 15193690 (Pubitemid 38757595)
26. Understanding late gadolinium enhancement in pulmonary hypertension. Bradlow WM, Assomull R, Kilner PJ, Gibbs SR, Sheppard MN, Mohiaddin RH, Circ Cardiovasc Imaging 2010 3 501 503 10.1161/CIRCIMAGING.109.919779 20647584